During the past decade, Holy Family Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 65 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 12 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Family Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Family Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "NRG Oncology" with 6 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Holy Family Medical Center" are "Breast Cancer" (14 trials), "Clear Cell Renal Cell Carcinoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Holy Family Medical Center" in a lesser frequency.

Most popular intervention types in "Holy Family Medical Center" are "Drug" (80 trials), "Other" (57 trials), "Biological" (39 trials), "Radiation" (12 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Bevacizumab" (16 trials), "Paclitaxel" (13 trials), "Quality-of-Life Assessment" (12 trials) and "placebo" (12 trials). Other intervention names were less common.

The vast majority of trials in "Holy Family Medical Center" are 71 trials for "All" genders and 21 trials for "Female" genders.

Currently, there are NaN active trials in "Holy Family Medical Center". undefined are not yet recruiting, 1 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Holy Family Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Family Medical Center, 10 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".